Neuvax is the most studied BC vaccine and is formulated with the E75 peptide, derived from HER2, recognized by MHC class I, and combined with the immune adjuvant granulocyte-macrophage colony-stimulating factor (GM-CSF). This evidence concerns the gene ERBB2 and breast cancer.